A URA3 null mutant of Candida albicans (CAI-4) causes oro-oesophageal and gastric candidiasis and is lethal for gnotobiotic, transgenic mice (Tgϵ26) that are deficient in both natural killer and T cells

References

1. Alani E., Cao L., Kleckner N. 1987; A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116:541–545 [CrossRef]
   [Google Scholar]
2. Bain J. M., Stubberfield C., Gow N. A. 2001; Ura-status-dependent adhesion of Candida albicans mutants. FEMS Microbiol Lett 204:323–328 [CrossRef]
   [Google Scholar]
3. Balish E., Warner T., Pierson C. J., Bock D. M., Wagner R. D. 2001; Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med Mycol 39:261–268 [CrossRef]
   [Google Scholar]
4. Balish E., Warner T. F., Nicholas P. J., Paulling E. E., Westwater C., Schofield D. A. 2005; Susceptibility of germfree phagocyte oxidase- and nitric oxide synthase 2-deficient mice, defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin. Infect Immun 73:1313–1320 [CrossRef]
   [Google Scholar]
5. Bendel C. M., Hess D. J., Garni R. M., Henry-Stanley M., Wells C. L. 2003; Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice. Crit Care Med 31:501–507 [CrossRef]
   [Google Scholar]
6. Brand A., MacCallum D. M., Brown A. J., Gow N. A., Odds F. C. 2004; Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell 3:900–909 [CrossRef]
   [Google Scholar]
7. Cheng S., Nguyen M. H., Zhang Z., Jia H., Handfield M., Clancy C. J. 2003; Evaluation of the roles of four Candida albicans genes in virulence by using gene disruption strains that express URA3 from the native locus. Infect Immun 71:6101–6103 [CrossRef]
   [Google Scholar]
8. Cole M. F., Bowen W. H., Zhao X. J., Cihlar R. L. 1995; Avirulence of Candida albicans auxotrophic mutants in a rat model of oropharyngeal candidiasis. FEMS Microbiol Lett 126:177–180 [CrossRef]
   [Google Scholar]
9. Domergue R., Castano I., De Las Penas A., Zupancic M., Lockatell V., Hebel J. R., Johnson D., Cormack B. P. 2005; Nicotinic acid limitation regulates silencing of Candida adhesins during UTI. Science 308:866–870 [CrossRef]
   [Google Scholar]
10. Fonzi W. A., Irwin M. Y. 1993; Isogenic strain construction and gene mapping in Candida albicans . Genetics 134:717–728
    [Google Scholar]
11. Hermann C., Hermann J., Munzel U., Ruchel R. 1999; Bacterial flora accompanying Candida yeasts in clinical specimens. Mycoses 42:619–627 [CrossRef]
    [Google Scholar]
12. Hogan D. A., Kolter R. 2002; Pseudomonas - Candida interactions: an ecological role for virulence factors. Science 296:2229–2232 [CrossRef]
    [Google Scholar]
13. Hogan D. A., Vik A., Kolter R. 2004; A Pseudomonas aeruginosa quorum-sensing molecule influences Candida albicans morphology. Mol Microbiol 54:1212–1223 [CrossRef]
    [Google Scholar]
14. Jackson B. E., Mitchell B. M., Wilhelmus K. R. 2007; Corneal virulence of Candida albicans strains deficient in Tup1-regulated genes. Invest Ophthalmol Vis Sci 48:2535–2539 [CrossRef]
    [Google Scholar]
15. Kirsch D. R., Whitney R. R. 1991; Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun 59:3297–3300
    [Google Scholar]
16. Kronstad J. W. 2007; Host-microbe interactions: the response of fungal and oomycete pathogens to the host environment. Curr Opin Microbiol 10:303–306 [CrossRef]
    [Google Scholar]
17. Lay J., Henry L. K., Clifford J., Koltin Y., Bulawa C. E., Becker J. M. 1998; Altered expression of selectable marker URA3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun 66:5301–5306
    [Google Scholar]
18. Littman M. L., Miwatani T. 1963; Effect of water soluble vitamins and their analogues on the growth of Candida albicans . I. Biotin pyridoxamine, pyridoxin, and fluorinated pyrimidines. Mycopathol Mycol Appl 21:81–108 [CrossRef]
    [Google Scholar]
19. Lo H. J., Kohler J. R., DiDomenico B., Loebenberg D., Cacciapuoti A., Fink G. R. 1997; Nonfilamentous C. albicans mutants are avirulent. Cell 90:939–949 [CrossRef]
    [Google Scholar]
20. Manning M., Snoddy C. B., Fromtling R. A. 1984; Comparative pathogenicity of auxotrophic mutants of Candida albicans . Can J Microbiol 30:31–35 [CrossRef]
    [Google Scholar]
21. Odds F. C. 1979; Structure, physiology and biochemistry of Candida . In Candida and Candidosis chapter 3: pp 16–28 Baltimore, MD: University Park Press;
    [Google Scholar]
22. Pfaller M. A. 1995; Epidemiology of candidiasis. J Hosp Infect 30:329–338 [CrossRef]
    [Google Scholar]
23. Pfaller M. A., Diekema D. J. 2007; Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133–163 [CrossRef]
    [Google Scholar]
24. Riggle P. J., Andrutis K. A., Chen X., Tzipori S. R., Kumamoto C. A. 1999; Invasive lesions containing filamentous forms produced by a Candida albicans mutant that is defective in filamentous growth in culture. Infect Immun 67:3649–3652
    [Google Scholar]
25. Savage N., Balish E. 1971; Morphology, physiology, and virulence of some mutants of Candida albicans . Infect Immun 3:141–148
    [Google Scholar]
26. Shepherd M. G. 1985; Pathogenicity of morphological and auxotrophic mutants of Candida albicans in experimental infections. Infect Immun 50:541–544
    [Google Scholar]
27. Staab J. F., Sundstrom P. 2003; URA3 as a selectable marker for disruption and virulence assessment of Candida albicans genes. Trends Microbiol 11:69–73 [CrossRef]
    [Google Scholar]
28. Sundstrom P., Cutler J. E., Staab J. F. 2002; Reevaluation of the role of HWP1 in systemic candidiasis by use of Candida albicans strains with selectable marker URA3 targeted to the ENO1 locus. Infect Immun 70:3281–3283 [CrossRef]
    [Google Scholar]
29. Wang B., Biron C., She J., Higgins K., Sunshine M. J., Lacy E., Lonberg N., Terhorst C. 1994; A block in both early T lymphocyte and natural killer cell development in transgenic mice with high-copy numbers of the human CD3E gene. Proc Natl Acad Sci U S A 91:9402–9406 [CrossRef]
    [Google Scholar]
30. Westwater C., Balish E., Warner T. F., Nicholas P. J., Paulling E. E., Schofield D. A. 2007; Susceptibility of gnotobiotic transgenic mice (Tgϵ26) with combined deficiencies in natural killer cells and T cells to wild-type and hyphal signalling-defective mutants of Candida albicans . J Med Microbiol 56:1138–1144 [CrossRef]
    [Google Scholar]
31. Wisplinghoff H., Seifert H., Wenzel R. P., Edmond M. B. 2003; Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103–1110 [CrossRef]
    [Google Scholar]
32. Yamaguchi H. 1974; Mycelial development and chemical alteration of Candida albicans from biotin insufficiency. Sabouraudia 12:320–328 [CrossRef]
    [Google Scholar]